| Mikiel Medical Mall, Pllc | |
|
3347 S 2nd St Abilene TX 79605-1760 | |
| (325) 208-3274 | |
| Not Available |
| Full Name | Mikiel Medical Mall, Pllc |
|---|---|
| Speciality | Family Medicine |
| Location | 3347 S 2nd St, Abilene, Texas |
| Authorized Official Name and Position | Indira Mikiel (OWNER) |
| Authorized Official Contact | 3252083274 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Mikiel Medical Mall, Pllc 3347 S 2nd St Abilene TX 79605-1760 Ph: () - | Mikiel Medical Mall, Pllc 3347 S 2nd St Abilene TX 79605-1760 Ph: (325) 208-3274 |
| NPI Number | 1083245815 |
|---|---|
| Provider Enumeration Date | 01/30/2020 |
| Last Update Date | 05/28/2020 |
| Medicare PECOS PAC ID | 4587092358 |
|---|---|
| Medicare Enrollment ID | O20200319001671 |
News Archive
The sickle cell trait could be a cause-albeit rare-of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions, April 1-3, in New Orleans.
The Seattle Times examines a partnership between the Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute (UCI). In 2008, "the two institutes formally agreed to collaborate on clinical care and research projects, and more recently a major building project at Uganda's only cancer-research center," the newspaper writes.
Patients taking the lipid-lowering medications atorvastatin, pravastatin, and simvastatin to reduce cholesterol levels, have a relatively low risk of developing rhabdomyolysis, (a disorder that causes the breakdown of muscle), according to a new study in the December 1 issue of JAMA.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083245815 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Amie Keawmanee |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1669841300 PECOS PAC ID: 7618286345 Enrollment ID: I20151021000501 |
News Archive
The sickle cell trait could be a cause-albeit rare-of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions, April 1-3, in New Orleans.
The Seattle Times examines a partnership between the Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute (UCI). In 2008, "the two institutes formally agreed to collaborate on clinical care and research projects, and more recently a major building project at Uganda's only cancer-research center," the newspaper writes.
Patients taking the lipid-lowering medications atorvastatin, pravastatin, and simvastatin to reduce cholesterol levels, have a relatively low risk of developing rhabdomyolysis, (a disorder that causes the breakdown of muscle), according to a new study in the December 1 issue of JAMA.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
| Provider Name | Indira Cassandra Maharaj-mikiel |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1891056164 PECOS PAC ID: 4789803743 Enrollment ID: I20161216000120 |
News Archive
The sickle cell trait could be a cause-albeit rare-of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions, April 1-3, in New Orleans.
The Seattle Times examines a partnership between the Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute (UCI). In 2008, "the two institutes formally agreed to collaborate on clinical care and research projects, and more recently a major building project at Uganda's only cancer-research center," the newspaper writes.
Patients taking the lipid-lowering medications atorvastatin, pravastatin, and simvastatin to reduce cholesterol levels, have a relatively low risk of developing rhabdomyolysis, (a disorder that causes the breakdown of muscle), according to a new study in the December 1 issue of JAMA.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
News Archive
The sickle cell trait could be a cause-albeit rare-of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions, April 1-3, in New Orleans.
The Seattle Times examines a partnership between the Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute (UCI). In 2008, "the two institutes formally agreed to collaborate on clinical care and research projects, and more recently a major building project at Uganda's only cancer-research center," the newspaper writes.
Patients taking the lipid-lowering medications atorvastatin, pravastatin, and simvastatin to reduce cholesterol levels, have a relatively low risk of developing rhabdomyolysis, (a disorder that causes the breakdown of muscle), according to a new study in the December 1 issue of JAMA.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 9 days ago
Agency Of The State Of Texas Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2616 S Clack, Ste 160, Abilene, TX 79606 Phone: 325-690-5131 Fax: 325-690-5228 | |
Stephen M. Osborn, Ph.d., P.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4601 Buffalo Gap Rd, Suite C-6, Abilene, TX 79606 Phone: 325-695-2232 Fax: 325-695-2233 | |
Regional Employee Assistance Program Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 6250 Regional Plz, Suite 1050, Abilene, TX 79606 Phone: 325-428-5740 Fax: 325-428-5749 | |
Big Country Internal Medicine Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4716 S 14th St, Abilene, TX 79605 Phone: 325-669-9569 | |
Sandra J Hazelip, Do, Pllc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 3202 S Willis St, Abilene, TX 79605 Phone: 325-695-4133 | |
Marshall Turnbull Md, Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1900 Pine St, Abilene, TX 79601 Phone: 325-676-4543 Fax: 325-672-9869 |